Join
Live feed
·
INSIDERFilingvia Quantisnow
TG Therapeutics Inc. logo

Director Echelard Yann sold $162,850 worth of shares (5,000 units at $32.57), decreasing direct ownership by 2% to 223,816 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TGTX· TG Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TGTX (TG Therapeutics Inc.) and more on Quantisnow.